T2 Biosystems, Inc.
(NASDAQ : TTOO)

( )
TTOO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.45%201.801.2%$542.05m
GILDGilead Sciences, Inc.
-1.21%73.270.9%$465.10m
BIIBBiogen Inc.
-2.95%320.411.3%$380.15m
CELGCelgene Corporation
-0.65%82.411.2%$337.48m
ILMNIllumina, Inc.
-2.60%313.103.5%$332.96m
REGNRegeneron Pharmaceuticals, Inc.
-1.36%389.832.6%$235.91m
VRTXVertex Pharmaceuticals Incorporated
-1.79%175.691.9%$230.46m
ALXNAlexion Pharmaceuticals, Inc.
-0.53%125.892.0%$220.48m
SRPTSarepta Therapeutics, Inc.
-3.30%134.2216.4%$169.84m
AAgilent Technologies, Inc.
-1.95%64.471.5%$159.28m
BMRNBioMarin Pharmaceutical Inc.
-0.58%103.224.4%$142.60m
LGNDLigand Pharmaceuticals Incorporated
-4.84%187.5223.3%$115.84m
EXASExact Sciences Corporation
-2.88%61.6425.3%$102.69m
NKTRNektar Therapeutics
-2.76%48.195.6%$101.86m
NBIXNeurocrine Biosciences, Inc.
-2.24%112.015.1%$98.21m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.